Plus: Biomutant Attacks, Elite's Odyssey Perplexes

This analysis examines the performance and market expectations for premium PC and console games during the third week of May 2021. Utilizing a proprietary "Hype" metric—which aggregates Steam wishlists, follower counts, and social media traction—the report identifies THQ Nordic’s Biomutant as the period's most anticipated release. With approximately 182,000 Steam followers and an estimated two million wishlists, the title demonstrates significant AAA-level interest despite being produced by a relatively small development team of twenty people.

The scope of the data covers major digital storefronts including Steam, the Nintendo Switch eShop, and the Epic Games Store (EGS). On Steam, Sony’s PC port of Days Gone showed strong initial momentum, securing over 3,000 positive reviews within four days. Conversely, the launch of Elite Dangerous: Odyssey faced significant headwinds, debuting with only 36% positive reviews due to technical bugs and performance issues. Other notable Steam performers include Mass Effect Legendary Edition and Resident Evil Village, which maintained high revenue positions.

On the Nintendo Switch, there is a growing trend of technically complex 3D ports finding commercial success, evidenced by the simultaneous Top 20 appearances of Subnautica and Subnautica: Below Zero in the UK charts. This suggests a potential shift in the Switch market away from its traditional reliance on "cute 2D indie" titles toward more demanding 3D experiences like SnowRunner.

Methodologically, the findings rely on data scrapes from Steam, Twitch, and manual chart tracking for the Switch and EGS. The re-introduction of EGS chart monitoring highlights a correlation between Steam and EGS revenue spikes for major releases like Days Gone, though the EGS rankings are currently influenced by the platform's "Mega Sale" event. Overall, the analysis underscores the difficulty of monitoring premium game performance across fragmented platforms while highlighting the critical role of pre-release "hype" in predicting commercial outcomes.